Breeze Meds vs Ro: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Breeze Meds beats Ro overall, scoring 7.3/10 vs 7.2/10. Ro is more affordable at $149/mo vs $199/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose Ro for users who want fda-approved brand-name glp-1 access includin.

A side-by-side comparison of Breeze Meds and Ro covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Breeze Meds

#34 of 48

7.3/10

Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.

Visit Breeze Meds

Ro

#44 of 48

7.2/10

One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.

Visit Ro

Feature	Breeze Meds	Ro
Our Score	7.3/10	7.2/10
Starting Price	$199/mo	$149/mo
Medication Type	Compounded	Brand
Insurance Accepted	No	Yes
Best For	Users who want a straightforward compounded GLP-1 program with fast shipping	Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing
Ranking	#34	#44

Pros & Cons Compared

Breeze Meds

Pros

+No subscription required — order on demand without recurring billing commitments
+Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
+FSA/HSA eligible for those with health savings accounts
+Discreet packaging on all shipments

Cons

−Very limited independent reviews and unclear company structure — legitimacy is hard to verify
−Oral options at $299-399/mo are significantly more expensive than injectable alternatives
−Not available in all 50 states — varies by provider licensure in your state

Ro

Pros

+Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
+Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
+Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
+Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available

Cons

−Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
−Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
−Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)

Our Verdict

Breeze Meds edges out Ro with a score of 7.3/10 vs 7.2/10. If budget is your priority, Ro starts at $149/mo compared to Breeze Meds's $199/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither Breeze Meds nor Ro feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Eden Health GLP-1→Read our full Eden Health GLP-1 review